Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
AbbVie, Vertex, Genmab among accurate biotech picks at SA for 2022 (NYSE:ABBV) Markets January 1, 2023 Panuwat Dangsungnoen/iStock by way of Getty Pictures Looking for Contributors urged traders to purchase AbbVie (NYSE:ABBV), Vertex Pharma (NASDAQ:VRTX), Genmab…
